These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 33101042)

  • 1. The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience.
    Gozzo L; Longo L; Vitale DC; Drago F
    Front Pharmacol; 2020; 11():588132. PubMed ID: 33101042
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
    Usha T; Middha SK; Kukanur AA; Shravani RV; Anupama MN; Harshitha N; Rahamath A; Kukanuri SA; Goyal AK
    Curr Protein Pept Sci; 2020 Sep; ():. PubMed ID: 32957901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
    Glinsky GV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data.
    Alakwaa FM
    mSystems; 2020 Apr; 5(2):. PubMed ID: 32291351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
    Das S; Camphausen K; Shankavaram U
    Res Sq; 2020 Jun; ():. PubMed ID: 32702730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational-based drug repurposing methods in COVID-19.
    Masoudi-Sobhanzadeh Y
    Bioimpacts; 2020; 10(3):205-206. PubMed ID: 32793443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations from the Italian Society of Pediatric Orthopaedics and Traumatology for the management of pediatric orthopaedic patients during the COVID19 pandemic and post-pandemic period in Italy.
    Trisolino G; Origo CE; De Sanctis N; Dibello D; Farsetti P; Gigante C; Guida P; Marengo L; Panuccio E; Toniolo RM; Verdoni F; Memeo A
    Ital J Pediatr; 2020 Oct; 46(1):149. PubMed ID: 33032650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Drug Repurposing for COVID-19 Therapy.
    Maldonado R; Drago F
    Front Pharmacol; 2021; 12():748886. PubMed ID: 34504433
    [No Abstract]   [Full Text] [Related]  

  • 9. On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients.
    Verbaanderd C; Rooman I; Meheus L; Huys I
    Front Pharmacol; 2019; 10():1664. PubMed ID: 32076405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.
    Forte G; Favieri F; Tambelli R; Casagrande M
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32531884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Warp Speed" Operations in the COVID-19 Pandemic: Moving Too Quickly?
    Van Norman GA
    JACC Basic Transl Sci; 2020 Jul; 5(7):730-734. PubMed ID: 32760859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Quarantine and Physical Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric Italian Population Trial.
    Giallonardo V; Sampogna G; Del Vecchio V; Luciano M; Albert U; Carmassi C; Carrà G; Cirulli F; Dell'Osso B; Nanni MG; Pompili M; Sani G; Tortorella A; Volpe U; Fiorillo A
    Front Psychiatry; 2020; 11():533. PubMed ID: 32581895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic.
    Fratino L; Procopio G; Di Maio M; Cinieri S; Leo S; Beretta G
    Front Oncol; 2020; 10():648. PubMed ID: 32426285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current regulatory approaches for accessing potential COVID-19 therapies.
    Halimi V; Daci A; Stojanovska S; Panovska-Stavridis I; Stevanovic M; Filipce V; Grozdanova A
    J Pharm Policy Pract; 2020; 13():16. PubMed ID: 32454981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap.
    Gozzo L; Longo L; Vitale DC; Drago F
    Front Pharmacol; 2020; 11():621934. PubMed ID: 33329008
    [No Abstract]   [Full Text] [Related]  

  • 16. The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries.
    Gozzo L; Romano GL; Brancati S; Longo L; Vitale DC; Drago F
    Front Pharmacol; 2023; 14():1169400. PubMed ID: 37188269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence, Drugs with Narrow Therapeutic Index and The Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution.
    Gozzo L; Caraci F; Drago F
    Healthcare (Basel); 2022 Jul; 10(8):. PubMed ID: 35893214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic.
    Puopolo M; Morciano C; Buoncervello M; De Nuccio C; Potenza RL; Toschi E; Palmisano L
    Trials; 2022 Jun; 23(1):527. PubMed ID: 35733167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revising the legislation of Ethics Committees to ease biomedical research in humans across the world: lessons from the COVID-19 emergency.
    Vinceti SR; Filippini T
    Acta Biomed; 2022 May; 93(2):e2021579. PubMed ID: 35546005
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.